Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curtiss-Wright Corporation (NYSE: CW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Curtiss-Wright is a global integrated business that supplies highly engineered products, solutions and services mainly to aerospace and defense markets, and critical technologies in commercial nuclear power, process and industrial markets. Its filings offer detailed insight into how these activities translate into financial results, risks and capital allocation decisions.
Through periodic reports such as Form 10-K and Form 10-Q, Curtiss-Wright presents segment information for Aerospace & Industrial, Defense Electronics, and Naval & Power, along with discussions of total aerospace and defense markets and total commercial markets. These documents typically include data on sales, operating income, operating margin, new orders, backlog and free cash flow, as well as commentary on factors such as product mix, restructuring initiatives and operational excellence programs.
Current reports on Form 8-K provide updates on specific events, including quarterly and annual earnings releases, changes to financial guidance, adoption of Rule 10b5-1 trading plans for share repurchases, and expansions of repurchase authorizations. These filings describe how Curtiss-Wright structures its repurchase programs, the amounts authorized, and the expected timing of purchases under those plans.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand segment performance, capital allocation actions and notable risk disclosures. Real-time updates from EDGAR, along with visibility into relevant forms such as 10-K, 10-Q and 8-K, allow investors and researchers to review Curtiss-Wright’s regulatory history and ongoing reporting in a structured, easy-to-navigate format.
Curtiss-Wright Corporation executive reports small stock sale under pre-set plan. EVP & Chief Growth Officer John C. Watts reported selling 288 shares of Curtiss-Wright common stock on January 8, 2026 at a price of $600 per share. After this transaction, he beneficially owns 3,188 shares directly. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 26, 2025 and was made in line with the company’s share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation executive John C. Watts reported a small planned stock sale. On 01/05/2026, he sold 107 shares of Curtiss-Wright common stock at a price of $578.84 per share. After this transaction, he beneficially owned 3,476 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Watts adopted on August 26, 2025 and was carried out by his financial advisor. The company notes that the shares were sold in line with its share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring additional common stock through deferred director compensation. On January 2, 2026, he acquired 727 shares of Curtiss-Wright common stock at a price of $572.38 per share, recorded as an acquisition. After this transaction, he beneficially owned 12,429 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation and receive annual restricted stock awards and fees in stock at a later date. The 727 shares relate to compensation earned in 2018, 2019, 2020, and 2021, with delivery deferred to January 2, 2026, and include dividend credits on outstanding awards.
Curtiss-Wright Corporation director stock award and deferral
A director of Curtiss-Wright Corporation acquired 981 shares of common stock on 01/02/2026, reported as an acquisition transaction. Following this award, the director beneficially owns 5,988 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation, including annual restricted stock awards and cash retainers, into stock to be received at a later date. The 981 shares relate to compensation earned in 2022 but deferred until January 2, 2026, with the number of shares determined by dividing the award value by the New York Stock Exchange closing price on the Board’s original approval date and rounded up to the nearest whole share, including related dividend credits. The reported price reference is the $572.38 NYSE closing price as of January 2, 2026.
Curtiss-Wright Corporation executive reports small stock purchase under employee plan. An Executive Vice President and Corporate Secretary of Curtiss-Wright Corporation acquired 21 shares of common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan. The shares were bought at a price of $472.17 per share, based on a 15% discount to the average selling price of the company’s stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, the reporting person beneficially owns 1,947 shares of Curtiss-Wright common stock directly. The transaction is described as exempt under Rules 16b-3(d) and 16b-3(c), reflecting a routine employee purchase rather than an open-market trade.
Curtiss-Wright Corporation executive John C. Watts, EVP & Chief Growth Officer, reported a small share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, he acquired 13 shares of Curtiss-Wright common stock at a price of $472.17 per share, as shown in Table I of the filing.
The ESPP purchase price reflects a 15% discount to the average selling price of Curtiss-Wright common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Watts directly beneficially owns 3,583 shares of Curtiss-Wright common stock. The company notes that this ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
Curtiss-Wright Corporation executive reports share purchase under employee plan. Executive Vice President and COO Kevin M. Rayment acquired 10 shares of Curtiss-Wright common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan (ESPP). The filing states the shares were bought at a price of $472.17 per share, determined with a 15% discount to the average selling price of the company’s common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Rayment beneficially owns 25,912 shares of Curtiss-Wright common stock, held directly.
Curtiss-Wright Corporation executive vice president and CFO K. Christopher Farkas reported a routine purchase of company stock under the employee stock purchase plan (ESPP). On 01/05/2026, he acquired 17 shares of Curtiss-Wright common stock at a price of $472.17 per share through the ESPP.
Following this transaction, he beneficially owns 4,253 shares of Curtiss-Wright common stock in direct ownership. The filing explains that under the ESPP, payroll deductions are made over a six-month offering period and used to buy shares at the end of the period, with the purchase price reflecting a 15% discount to the average selling price on 12/31/2025, the last day of that offering period.
Curtiss-Wright Corporation's Chair and CEO, who also serves as a director, reported a routine share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, the reporting person acquired 22 shares of common stock at a price of $472.17 per share through the ESPP, which uses payroll deductions collected over a six-month offering period.
Following this transaction, the reporting person directly owns 35,251 shares of Curtiss-Wright common stock. The filing notes that the ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c), reflecting a standard employee share purchase rather than a discretionary open-market trade.
Curtiss-Wright Corporation officer reports small stock sale under 10b5-1 plan
An officer of Curtiss-Wright Corporation (CW), serving as Vice President of Strategy & Business Development, reported selling 118 shares of common stock on 12/23/2025 at a price of $575 per share. After this transaction, the officer beneficially owns 3,570 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 26, 2025 and is maintained by the officer's financial advisor. The filing notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those guidelines.
FAQ
What is the current stock price of Curtiss Wright (CW)?
What is the market cap of Curtiss Wright (CW)?
